GSE111247 temozolomide LN-308 2 v 9 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE111247_temozolomide_LN-308_2_v_9_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE111247_temozolomide_LN-308_2_v_9_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE111247_temozolomide_LN-308_2_v_9_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE111247_temozolomide_LN-308_2_v_9_human_up.

Results found

Linked to

 

Label

Description

 

Gene

PAX8 antisense RNA 1

Gene

keratin 16 pseudogene 3

Gene

long intergenic non-protein coding RNA 3022

Gene

long intergenic non-protein coding RNA 1580

Gene

long intergenic non-protein coding RNA 1564

Gene

CFAP144 pseudogene 1

Gene

ELOVL2 antisense RNA 1

Gene

uncharacterized LOC124906232

Gene

CAP1 pseudogene 1

Gene

long intergenic non-protein coding RNA 1585

  • Gene

    PAX8 antisense RNA 1


  • Gene

    keratin 16 pseudogene 3


  • Gene

    long intergenic non-protein coding RNA 3022


  • Gene

    long intergenic non-protein coding RNA 1580


  • Gene

    long intergenic non-protein coding RNA 1564


  • Gene

    CFAP144 pseudogene 1


  • Gene

    ELOVL2 antisense RNA 1


  • Gene

    uncharacterized LOC124906232


  • Gene

    CAP1 pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 1585

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.